Disease Activity in Psoriatic Arthritis: Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World
Ideal target for psoriatic arthritis? Comparison of remission and low disease activity states in a real-life cohort | Annals of the Rheumatic Diseases
Correlation of patient‐reported routine assessment of patient index data with clinical measures of disease activity in psoriatic arthritis - Ward - 2022 - International Journal of Rheumatic Diseases - Wiley Online Library
Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients | SpringerLink
Disease activity and response assessment in psoriatic arthritis using the Disease Activity index for PSoriatic Arthritis (DAPSA). A brief review. | Semantic Scholar
Radiographic Progression in Psoriatic Arthritis Achieving a Good Response to Treatment: Data Using Newer Composite Indices of Disease Activity - Helliwell - 2018 - Arthritis Care & Research - Wiley Online Library
Response to: 'To DAPSA or not to DAPSA? That is not the question' by Schoels et al | Annals of the Rheumatic Diseases
PDF) Evaluation of the Disease Activity index for PSoriatic Arthritis (DAPSA) with a quick quantitative C reactive protein assay (Q-DAPSA) in patients with psoriatic arthritis: a prospective multicentre cross-sectional study
Supplementary Table 1. Calculation of DAPSA and CPDAI and CPDAI disease activity categories (modified from [1,2]) Disease Activi
MDA Versus DAPSA: Applicability in a Real World - ACR Meeting Abstracts
DAPSA (Disease Activity in PSoriatic Arthritis) Score
Comparison of remission and low disease activity states with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 study - ScienceDirect
Measures of psoriatic arthritis: Tender and Swollen Joint Assessment, Psoriasis Area and Severity Index (PASI), Nail Psoriasis Severity Index (NAPSI), Modified Nail Psoriasis Severity Index (mNAPSI), Mander/Newcastle Enthesitis Index (MEI), Leeds ...
Validación del índice compuesto DAPSA (Disease Activity for Psoriatic Arthritis) en una cohorte de pacientes con artritis psoriásica en Argentina y determinación de sus valores de corte
Q&A: A Quick Quantitative C-Reactive Protein Assay-Based DAPSA in Patients With Psoriatic Arthritis
Disease Activity in Psoriatic Arthritis: Comparison of the Discriminative Capacity and Construct Validity of Six Composite Indices in a Real World
Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score | Annals of the Rheumatic Diseases
Comparison of remission and low disease activity states with DAPSA, MDA and VLDA in a clinical trial setting in psoriatic arthritis patients: 2-year results from the FUTURE 2 study - ScienceDirect
Dapsa Eng | PDF
Validation of the Disease Activity Index for Psoriatic Arthritis (DAPSA) with a Quick QuantitativeC-reactive Protein Assay (Q-DAPSA) in Patients with Psoriatic Arthritis (PsA): A Prospective,national, Multicenter Study - ACR Meeting Abstracts
Disease activity categories by Q-DAPSA vs. DAPSA | Download Scientific Diagram
The state of the art—psoriatic arthritis outcome assessment in clinical trials and daily practice - The Lancet Rheumatology
DAPSA versus cDAPSA: Do we need to use CRP? | Annals of the Rheumatic Diseases
RheumaHelper - Apps on Google Play
Disease activity in psoriatic arthritis (PsA): defining remission and treatment success using the DAPSA score | Annals of the Rheumatic Diseases
Treat to Target in Spondyloarthritis: Myth or Reality? - European Medical Journal
Treating Psoriasis and Psoriatic Arthritis: Position Paper on Applying the Treat-to-target Concept to Canadian Daily Practice | The Journal of Rheumatology
LS mean change from baseline in (a) PASDAS, (b) DAPSA, and (c) CPDAI.... | Download Scientific Diagram
